Obstructive Sleep Apnea: Clinical Trials

43 trials for Obstructive Sleep Apnea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 completed. 43 Phase 2, 5 Phase 1, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 243Completed 43
Phase 15Completed 5
Phase 35Completed 5

Follow Obstructive Sleep Apnea: new trials by email Literature Review of Obstructive Sleep Apnea trials Research Report on Obstructive Sleep Apnea

Trials (filtered) newest first · largest first

All 43 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension
Lorundrostat, Placebo - Obstructive Sleep Apnea, Hypertension
Phase 2CompletedMineralys Therapeutics Inc.482025-02-282026-08-21
RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA
IHL-42X Low Dose, IHL-42X High Dose, Placebo - Obstructive Sleep Apnea
Phase 2 / Phase 3CompletedIncannex Healthcare Ltd1212024-05-022026-07-27
Managing Opioid Related Sleep Apnea With Acetazolamide
Acetazolamide, Placebo - Sleep-Disordered Breathing, Obstructive Sleep Apnea
Phase 2CompletedUniversity of California, San Diego392023-10-182026-03-10
Endotype-Targeted Therapy to Rescue OSA Patients Struggling With CPAP Adherence (TOP-CPAP)
Eszopiclone 2 mg, Placebo - Obstructive Sleep Apnea
Phase 2CompletedUniversity of California, San Diego422023-08-312025-11-25
AD816 Crossover Study
Period A, Period B, Period C - OSA, Obstructive Sleep Apnea
Phase 2CompletedApnimed252023-04-282023-11-15
Acetazolamide on REM OSA
Placebo oral capsule, Acetazolamide - Obstructive Sleep Apnea
Phase 1 / Phase 2CompletedBrigham and Women's Hospital112023-01-302026-01-20
Acetazolamide for Obstructive Sleep Apnea to Improve Heart Health
Acetazolamide, Placebo, Continuous Positive Airway Pressure - Obstructive Sleep Apnea
Phase 2CompletedUniversity of California, San Diego542022-12-022025-11-25
Pediatric Pain Optimization After Tonsillectomy
Fentanyl/Hydromorphone, Methadone - Obstructive Sleep Apnea, Tonsillitis
Phase 2CompletedDuke University662022-04-082024-10-17
Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)
Sulthiame - Obstructive Sleep Apnea
Phase 2CompletedDesitin Arzneimittel GmbH2982021-11-232023-11-29
Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)
Dosing 1: Atomoxetine, AD313 - Obstructive Sleep Apnea
Phase 1 / Phase 2CompletedApnimed152021-10-192023-04-07
Prospective Randomized Trial of CPAP for SDB in Patients Who Use Opioids
Positive Airway Pressure (PAP) - Sleep Disorder; Breathing-Related, Pain
Phase 2CompletedUniversity of California, San Diego622021-08-102024-12-02
Trial of AD113 and Atomoxetine in OSA Patients With Hypertension
AD113, Atomoxetine - Obstructive Sleep Apnea, Hypertension
Phase 2CompletedApnimed212021-07-312023-08-21
AD109 Dose Finding in Mild to Moderate OSA
AD109 dose1- A, AD109 dose2- B, Placebo- C - Obstructive Sleep Apnea
Phase 2CompletedApnimed322020-12-222022-12-22
Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea
AD182, AD504, Placebo - Obstructive Sleep Apnea
Phase 2CompletedApnimed152020-12-012022-09-02
Combination Drug-Therapy for Patients With Untreated Obstructive Sleep Apnea
Acetazolamide, Eszopiclone, Placebo - OSA, Obstructive Sleep Apnea
Phase 2CompletedUniversity of California, San Diego202020-12-012024-05-29
Crossover Trial of AD109 in Obstructive Sleep Apnea
AD109, Atomoxetine, R-oxybutynin - Obstructive Sleep Apnea
Phase 2CompletedApnimed602020-10-272023-01-31
Medications for Obstructive Sleep Apnea In Children With Down Syndrome
Atomoxetine and oxybutynin (ato-oxy) - Obstructive Sleep Apnea, Down Syndrome
Phase 2CompletedUniversity of Arizona222020-10-212025-08-19
Do Endotypes Predict Response and Sequelae in OSA Patients
Eszopiclone, Supplemental Oxygen, Continuous Positive Airway Pressure (CPAP) - Obstructive Sleep Apnea, Sleep Apnea
Phase 2CompletedUniversity of California, San Diego2332020-08-012026-06-18
Crossover Trial of AD036 in Obstructive Sleep Apnea
AD036, Atomoxetine, Placebo - Obstructive Sleep Apnea
Phase 2CompletedApnimed622020-07-152023-09-14
Study of AD128 Versus Placebo in Obstructive Sleep Apnea
AD128, Placebo - Obstructive Sleep Apnea
Phase 2CompletedIstituto Auxologico Italiano202020-07-032021-09-27

Showing 20 of 43. Sign in to see all of them.

Narrower conditions

Sleep Apnea, Obstructive (43)  ·  Sleep Apnea Syndromes (14)  ·  Hypertension (6)  ·  Sleep Wake Disorders (4)  ·  Apnea (2)  ·  Cardiovascular Diseases (2)  ·  Chronic Pain (2)  ·  Obesity (2)  ·  Pain (2)  ·  Respiration Disorders (2)  ·  Stroke (2)  ·  Brain Ischemia (1)  ·  Coronary Artery Disease (1)  ·  Disorders of Excessive Somnolence (1)  ·  Down Syndrome (1)

Broader conditions

Dyssomnias (43)  ·  Nervous System Diseases (43)  ·  Respiratory Tract Diseases (43)  ·  Sleep Disorders, Intrinsic (43)  ·  Apnea (41)  ·  Respiration Disorders (41)  ·  Sleep Wake Disorders (39)  ·  Sleep Apnea Syndromes (29)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Signs and Symptoms (10)  ·  Neurologic Manifestations (8)  ·  Vascular Diseases (7)  ·  Cardiovascular Diseases (5)  ·  Mental Disorders (5)  ·  Signs and Symptoms, Respiratory (4)

Interventions

Continuous Positive Airway Pressure (10)  ·  Acetazolamide (6)  ·  Atomoxetine Hydrochloride (5)  ·  Eszopiclone (3)  ·  Occlusal Splints (2)  ·  (Lys-Gly)(5)cyclo(75-82)MBP(74-85) (1)  ·  Adrenergic beta-Antagonists (1)  ·  Bosentan (1)  ·  Celecoxib (1)  ·  Combined Modality Therapy (1)  ·  Dimethyl Fumarate (1)  ·  Dronabinol (1)  ·  Fentanyl (1)  ·  Hydromorphone (1)  ·  Indomethacin (1)

Sponsors

Apnimed (8)  ·  University of California, San Diego (6)  ·  Brigham and Women's Hospital (5)  ·  Apnex Medical, Inc. (2)  ·  Göteborg University (2)  ·  Johns Hopkins University (2)  ·  Associação Fundo de Incentivo à Pesquisa (1)  ·  Desitin Arzneimittel GmbH (1)  ·  Duke University (1)  ·  Hubei Hospital of Traditional Chinese Medicine (1)  ·  Incannex Healthcare Ltd (1)  ·  Istituto Auxologico Italiano (1)  ·  Jazz Pharmaceuticals (1)  ·  Mineralys Therapeutics Inc. (1)  ·  Nykøbing Falster County Hospital (1)

Countries

United States (30)  ·  Australia (2)  ·  Sweden (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)

Top investigators

Christopher Schmickl, MD, PhD (2)  ·  Jan Hedner, MD. Prof. (2)  ·  Jeremy Orr, MD (2)  ·  Ron Farkas, MD (2)  ·  Alan R Schwartz, M.D. (1)  ·  Atul Malhotra, MD (1)  ·  Beth Malow, M.D., M.S. (1)  ·  Bradley A Edwards, PhD (1)  ·  Bruce Corser, MD (1)  ·  Carol Rosen, M.D. (1)  ·  Christopher E Kline, MS (1)  ·  Christopher N Schmickl, MD, PhD (1)  ·  Christopher Schmickl (1)  ·  Con Iber, MD (1)  ·  Daniel Combs, MD (1)

Results publications

PMID 18513353, PMID 18711110, PMID 21885958, PMID 22043118, PMID 22131599, PMID 22334806, PMID 22547887, PMID 22572632, PMID 22893765, PMID 22968110, PMID 24458967, PMID 24815497, PMID 24918372, PMID 25892349, PMID 26643404, PMID 29035093, PMID 29510792, PMID 29800466, PMID 32649638, PMID 34225174, PMID 34543665, PMID 35551600, PMID 35975547, PMID 36494591, PMID 36734173, PMID 36805833, PMID 37555595, PMID 37938917, PMID 38507976, PMID 38669011, PMID 39305436, PMID 39514000, PMID 39688178, PMID 40360261, PMID 40705710, PMID 41077049, PMID 41424523, PMID 41781273, PMID 41811641

NIH funding

K23HL151880 (2), 2009 (1), 2015 (1), 2019 (1), R01HL106410 (1), R01HL128658 (1), R01NS042698 (1), R03HL138068 (1), R61HL151254 (1), UL1RR024989 (1)